Comparative dosimetric assessment of combined treatment modalities in cervical cancer radiotherapy for optimal organ protection

被引:0
|
作者
Gazsi, Iozsef [1 ,2 ]
Marcu, Loredana G. [3 ,4 ]
机构
[1] West Univ Timisoara, Fac Phys, Timisoara 300223, Romania
[2] Emergency Cty Hosp, Oradea 410167, Romania
[3] Univ South Australia, UniSA Allied Hlth & Human Performance, Adelaide, SA 5001, Australia
[4] Univ Oradea, Fac Informat & Sci, Oradea 410087, Romania
关键词
3D-conformal radiotherapy; Intensity modulated radiotherapy; Volumetric modulated arc therapy; Brachytherapy; Organs at risk; Combined radiotherapy; Dosimetry; GUIDED ADAPTIVE BRACHYTHERAPY; INTRACAVITARY BRACHYTHERAPY; CLINICAL-OUTCOMES; VOLUME; CHEMORADIATION; PARAMETERS; CARCINOMA; APPLICATORS; EVOLUTION; HEAD;
D O I
10.1007/s00411-025-01113-7
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
External radiotherapy combined with internal radiotherapy in cervical cancer can provide a boost to the target volume to increase tumour control. At the same time internal radiotherapy protects neighboring organs. The aim of the present study was to dosimetrically compare three external beam radiotherapy techniques each combined with internal radiotherapy to evaluate the combination that offers the best organ protection. Treatment plans of 20 cervical cancer patients were created for external (including three-dimensional conformal radiotherapy (3D-CRT), intensity modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT)) as well as brachytherapy. The prescribed dose was 50 Gy in 25 fractions for external and 21 Gy in three fractions for internal radiotherapy. The following organs at risk (OARs) were evaluated: bladder, rectum, sigmoid and bowel bag. The study analyzed the results of different treatment combinations in terms of dosimetric values for various parameters. The D90 for the clinical target volume was around 120 Gy, with the highest value seen in 3D-CRT + BT (brachytherapy) combination at 120.59 Gy. For the bladder, the D2cc remained below the recommended threshold of 90 Gy, with the lowest value obtained for the BT + IMRT combination at 79.2 Gy. For the rectum, both D2cc and D1cc remained below the recommended threshold of 75 Gy for both parameters. All techniques fell below the recommended dose of 75 Gy for the sigmoid. For the intestine, there were statistically significant differences between BT + IMRT and BT + 3D-CRT. The VMAT technique showed superiority over IMRT in tumour volume coverage and several organ-at-risk parameters. Generally, intensity-modulated techniques showed dosimetric advantage over the traditional 3D technique in cervical cancer. In addition to providing better compliance and homogeneity, they provided superior protection for organs at risk, especially for bowel bag. It is concluded that the BT + IMRT technique provided the best protection for organs at risk based on the lowest OAR dosimetric values, especially for the intestine.
引用
收藏
页码:291 / 302
页数:12
相关论文
共 50 条
  • [21] Dosimetric impact of automatic segmentation of organs at risk in cervical cancer radiotherapy
    Trivellato, Sara
    Bordigoni, Bianca
    Pellegrini, Roberto
    Meregalli, Sofia
    Bonetto, Elisa Maria
    Montanari, Gianluca
    Daniotti, Martina Camilla
    Carminati, Stefano
    Arcangeli, Stefano
    De Ponti, Elena
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S3150 - S3151
  • [22] Dosimetric evaluation of variation in Library of plans selection for cervical cancer radiotherapy
    de Hond, Yvonne J. M.
    van Haaren, Paul M. A.
    Verrijssen, An-Sofie E.
    Tijssen, Rob H. N.
    Hurkmans, Coen W.
    RADIOTHERAPY AND ONCOLOGY, 2025, 206
  • [23] What Is the Comparative Efficacy of Surgical, Endoscopic, Transanal Resection, and Radiotherapy Modalities in the Treatment of Rectal Cancer?
    Isaic, Alexandru
    Motofelea, Alexandru Catalin
    Costachescu, Dan
    Pop, Gheorghe Nicusor
    Totolici, Bogdan
    Popovici, Dorel
    Diaconescu, Razvan Gheorghe
    HEALTHCARE, 2023, 11 (16)
  • [24] RADIOTHERAPY AND COMPLEMENTARY TREATMENT FOR CERVICAL CANCER
    Moreno Acosta, P.
    Cotes Mestre, M.
    Gamboa, O.
    Magne, N.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 880 - 880
  • [25] A comparative analysis of toxicity and treatment outcomes of adaptive radiotherapy and intensity-modulated radiotherapy in cervical cancer
    Liu, Xiaohan
    Tian, Wei
    Dai, Anli
    Li, Hui
    Zhu, Mei
    Zeng, Mengsi
    Feng, Ronghua
    Zhang, Zhenyu
    Jiang, Xiaosong
    Wen, Yu
    Wu, Tao
    Xiao, Zemin
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [26] Modelling the dosimetric consequences of organ motion at CT imaging on radiotherapy treatment planning
    Booth, JT
    Zavgorodni, SF
    PHYSICS IN MEDICINE AND BIOLOGY, 2001, 46 (05): : 1369 - 1377
  • [27] Comparative Dosimetric Analysis of Combined Intracavitary and Interstitial Needles Placement vs. Intracavitary Alone for Cervical Cancer
    Shiao, J. C.
    Patton, T. J.
    Holt, D. E.
    Robin, T. P.
    Fisher, C. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E379 - E379
  • [28] MRI Assessment of Cervical Cancer for Adaptive Radiotherapy
    Dimopoulos, Johannes C. A.
    Schirl, Gertrude
    Baldinger, Anja
    Helbich, Thomas H.
    Poetter, Richard
    STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 (05) : 282 - 287
  • [29] Is intracavitary brachytherapy really optimal in cervical cancer radiotherapy?
    Piotrkowicz, N.
    Kawczynska, M.
    Czyzew, B.
    Gruszczynska, E.
    Michalski, W.
    Krawczyk-Pisarska, M.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S264 - S264
  • [30] Use of G-CSF (Neupogen®) in combined modalities treatment in radiotherapy
    Bartzsch, O
    Riepl, M
    Busch, M
    Michael, G
    Allgauer, M
    Voss, AC
    Sauer, R
    Duhmke, E
    Gademann, G
    Molls, M
    STRAHLENTHERAPIE UND ONKOLOGIE, 1998, 174 (11) : 551 - 555